ETD vs NBIX · P/E 13, rev $614.6M vs P/E 45, rev $2.36B
Ethan Allen Interiors Inc (ETD) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Ethan Allen Interiors Inc (ETD) is a furnishings, fixtures & appliances company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ETD revenue for 2025-06-30 was $614.6M. Net income was $51.6M. Revenue was down 4.9% from 2024-06-30 to 2025-06-30. ETD currently screens at market cap $526.0M and trailing P/E 13.1.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ETD currently screens at market cap $526.0M and trailing P/E 13.1. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ETD and NBIX stock pages for the full models.
Not investment advice.